- 7/24 Live Call Center
Classic Ehlers-Danlos syndrome, also known as Ehlers-Danlos syndrome Type 2, is a genetic disorder. It affects the body’s connective tissue. People with this condition have skin hyperextensibility, fragile skin, slow wound healing, and very flexible joints eds type 2.
At Liv Hospital, we understand the challenges of diagnosing and treating this rare disorder. It is passed down in an autosomal dominant way. This means about half of those affected get it from a parent, and the other half get it from a new mutation.
Knowing about this condition is key to managing it well. We aim to offer full support and education to those affected.
To understand EDS Type 2, we need to explore its definition, classification, and how common it is. This knowledge is key for diagnosing and treating the condition. Ehlers-Danlos Syndrome (EDS) affects the connective tissue in our skin, bones, and organs.
Classic Ehlers-Danlos Syndrome, or EDS Type 2, has its own set of genetic and clinical signs. It falls within the EDS spectrum, which mainly affects connective tissue. Most people with classic EDS have mutations in the COL5A1 or COL5A2 genes, which are important for understanding the syndrome.
EDS Type 2 is classified based on its clinical features. These include skin that stretches too much, joints that move too far, and tissues that break easily. These signs help doctors tell EDS Type 2 apart from other EDS types.
EDS Type 2 affects about 1 in 20,000 to 40,000 people worldwide. It’s less common than hypermobile EDS but more common than vascular EDS. The number of people with EDS Type 2 varies by region, showing the need for tailored healthcare.
Knowing how common EDS Type 2 is helps doctors treat it better. It also shows the importance of genetic counseling and support for those affected and their families.
Classic Ehlers-Danlos syndrome, or EDS Type 2, is mainly caused by changes in the COL5A1 or COL5A2 genes. These genes are important for making type V collagen. Studies have found that most people with classic EDS have mutations in these genes.
The genetics of EDS Type 2 are complex. It involves problems with collagen assembly. Changes in COL5A1 and COL5A2 affect not just type V collagen but also types I and III. This leads to symptoms like very stretchy skin and loose joints.
Knowing the genetic roots of EDS Type 2 is key for diagnosis and treatment. The condition shows up differently in everyone. So, a detailed genetic test is vital for creating the right treatment plan.
EDS Type 2, also known as Classic Ehlers-Danlos syndrome, is a genetic disorder. It affects the body’s connective tissue. It’s known for skin that stretches too far, joints that move too much, and tissues that break easily.
Even though it shares some traits with other EDS types, its unique genetic and clinical features make it stand out.
Classic EDS is marked by very flexible joints and skin that stretches a lot. It also makes wound healing slow, leading to wide, thin scars. People with this condition often bruise easily and have fragile blood vessels.
Diagnosing EDS Type 2 involves a clinical evaluation, medical history, and genetic testing. The diagnosis is confirmed by finding mutations in the COL5A1 or COL5A2 genes.
EDS Type 2 is estimated to affect 1 in 20,000 to 1 in 40,000 people. It affects both males and females equally and is found worldwide, across all ethnic backgrounds.
Managing EDS Type 2 aims to ease symptoms, prevent complications, and improve life quality. This includes physical therapy, pain management, and wound care. Sometimes, surgery is needed to address specific issues.
There is no cure for EDS Type 2. It’s a lifelong condition that needs ongoing care. But, with the right treatment and lifestyle changes, people with Classic EDS can live active, fulfilling lives.
Yes, making some lifestyle changes can help manage symptoms and prevent complications. Avoiding heavy lifting or bending, wearing protective gear, and keeping a healthy weight can reduce joint stress.
National Center for Biotechnology Information. Evidence-Based Medical Guidance. Retrieved from https://pubmed.ncbi.nlm.nih.gov/28046032/
